SEC Filing Document

Company: DUKE Robotics Corp.
Ticker: DUKR
CIK: 1638911
Filing Type: 8-K
Document Type: EX-4.1
Date Filed: 2026-01-05
Accession Number: 0001213900-26-000765
Exchange: OTC
SIC Code: 3721
SIC Description: Aircraft
URL: https://www.sec.gov/Archives/edgar/data/1638911/000121390026000765/ea027141601ex4-1_duke.htm

Chunk 4 of 5
Word Count: 730
Character Count: 4568

Document Content:

times in good faith assist in the carrying out of all such terms and in the taking of all such action as may be necessary or appropriate in order to protect the rights of the Holder contained herein against impairment. (g) Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of any such loss, theft or destruction, upon delivery of an indemnity agreement reasonably satisfactory in form and amount to the Company, or, in the case of any such mutilation, upon surrender and cancellation of such Warrant, the Company, at its expense, will execute and deliver to the Holder, in lieu thereof, a new Warrant of like date and tenor. (h) This Warrant and any provision hereof may be amended, waived or terminated only by an instrument in writing signed by the Company and the Holder.

(i)  The
remedies provided in this Warrant shall be cumulative and in addition to all other remedies available under this Warrant and the other
Transaction Documents, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein
shall limit the right of the Holder to pursue actual damages for any failure by the Company to comply with the terms of this Warrant.
The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy
at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach,
the holder of this Warrant shall be entitled, in addition to all other available remedies, to an injunction restraining any breach, without
the necessity of showing economic loss and without any bond or other security being required.

[signature page follows]

IN WITNESS WHEREOF, the Company
has caused this Warrant to be signed by its duly authorized officer.

DUKE Robotics CORP.

Name:	Yossef Balucka

Title:	CEO

Exhibit A

NOTICE OF EXERCISE

TO:	DUKE Robotics Corp.

Attention: CEO

The undersigned hereby elects
to purchase the below referenced shares (the “Warrant Shares”) of Common Stock of DUKE Robotics Corp. (the “Company”)
pursuant to the terms of the attached Warrant, and tenders herewith payment of the purchase price of such Warrant Shares in full. Payment
of the purchase price is being made by:

_________________ a cash exercise with
respect to _________________   Warrant Shares.

Please issue a certificate
or certificates representing said shares in the name of the undersigned or in such other name as is specified below:

1.	Name: _________________

2.	Address: _________________

3.	DWAC Instructions (if applicable):___________________

The undersigned hereby
represents and warrants the following:

(i) has such knowledge and experience in financial and business affairs that he/she/it is capable of evaluating the merits and risks involved
in purchasing the Warrant Shares, (ii) is able to bear the economic risks involved in purchasing the Warrant Shares, and (iii) is a “non-US
person” as defined in Regulation S or an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7)
or (a)(8) promulgated under the Securities Act of 1933, as amended;

making the decision to purchase the Warrant Shares, it has relied solely on independent investigations made by it and has had the opportunity
to ask questions of, and receive answers from, the Company concerning the Warrant Shares, the financial condition, prospective business
and operations of the Company and has otherwise had an opportunity to obtain any additional information, to the extent that the Company
possess such information or could acquire it without unreasonable effort or expense;

(c) Its
overall commitment to investments that are not readily marketable is not disproportionate to its net worth and income, and the purchase
of the Warrant Shares will not cause such overall commitment to become disproportionate; it can afford to bear the loss of the purchase
price of the Warrant Shares;

has no present need for liquidity in its investment in the Warrant Shares; and

acknowledges that the transaction contemplated in connection with the purchase of the Warrant Shares has not been reviewed or approved
by the Securities and Exchange Commission or by any administrative agency charged with the administration of the securities laws of any
state, and that no such agency has passed on or made any recommendation or endorsement of any of the securities contemplated hereby.

(Signature and Date)